⌘K

Home/Filings/4/0001209191-13-034397

4//SEC Filing

Trius Therapeutics Inc 4

Accession 0001209191-13-034397

CIK 0001356857operating

View on SEC.gov Company Profile

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 4:44 PM ET

Size

4.7 KB

Accession

0001209191-13-034397

Insider Transaction Report

Form 4

Period: 2013-07-01

Trius Therapeutics IncTSRX

Chief Development Officer

Transactions

Sale
Common Stock
2013-07-01$8.14/sh−2,000$16,280→ 95,300 total

Footnotes (1)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2012

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Trius Therapeutics Inc

CIK 0001356857

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001356857

Filing Metadata

Form type: 4
Filed: Jun 30, 8:00 PM ET
Accepted: Jul 1, 4:44 PM ET
Size: 4.7 KB

View on SEC.gov